Sociedad Quimica y Minera de Chile SA (SQM US)
SQM US$56.37
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 56.37
- Change
- ▼ -2.57 (-4.36)
- Bid / Ask
- 56.35 - 56.41
- Volume
- 197,464
- Turnover
- 8,180,403
- Open
- 57.17
- Day Range
- 56.36 - 57.27
- VWAP
- 56.50
- Prev Close
- 58.94
- Last Trade
- 29/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Basic Materials
- Shares Issued
- 142,818,904
- NTA/Share
- 19.72
- Last Dividend
- 1.40
- Dividend Ex Date
- 8 SEP 2026
- Dividend Pay Date
- 21 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 4,576.22
- EBITDA
- 1,477.11
- Profit
- 588.14
- Earnings Per Share (EPS)
- 2.06
- Dividend Per Share (DPS)
- —
- Yield %
- 4.11
- Market Cap
- 16,101.40
- Price to Earnings Ratio (P/E)
- 11.60
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 7,465.18
- EBITDA
- 3,071.00
- Profit
- 1,802.02
- Earnings Per Share (EPS)
- 6.31
- Dividend Per Share (DPS)
- 3.79
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 61.97 Fair value 73.61 One-star price 87.44
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 73.61
- Price / Fair Value
- 0.80
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (61.97) to the one-star price (87.44).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 58.94 |
| Price - 12 month high | 97.99 |
| Price - 12 month low | 43.41 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.13 |
| Market capitalization | 8,417.75 |
| 12 Month High price date | 7 MAY 2026 |
| 12 Month Low price date | 28 OCT 2025 |
| Volume - avg. trading volume for the last 3 months | 0.98 |
| Price - 1 Day % Change | -2.26% |
| Price - 13 week price percent change | -11.86% |
| Price - 26 week price percent change | -34.09% |
| Price - 5 Day % Change | 0.86% |
| Price - 52 week price percent change | 31.83% |
| Price - YTD price percent change | -14.55% |
| Price % Change Month To Date | -9.55% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 2.059 |
| EPS excluding extraordinary items - trailing 12 month | 4.858 |
| EPS Normalized - most recent fiscal year | 2.108 |
| Revenue/share - most recent fiscal year | 16.021 |
| Revenue/share - trailing 12 month | 23.567 |
| Book value per share - most recent fiscal year | 19.925 |
| Book value per share - most recent quarter | 22.095 |
| Book value (tangible) per share - most recent fiscal year | 19.721 |
| Book value (tangible) per share - most recent quarter | 30.376 |
| Cash per share - most recent fiscal year | 6.128 |
| Cash per share - most recent quarter | 11.822 |
| Cash Flow per share - most recent fiscal year | 4.602 |
| Cash Flow per share - trailing 12 month | 9.700 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 2.425 |
| EBITD per share - trailing 12 month | 8.958 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 2.059 |
| EPS Basic excluding extraordinary items - trailing 12 month | 4.858 |
| EPS including extraordinary items - most recent fiscal year | 2.059 |
| EPS including extraordinary items - trailing 12 month | 4.858 |
| Free Cash Flow per share - trailing 12 month | 6.857 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 12.13 |
| P/E Normalized, most recent fiscal year | 12.02 |
| Price to sales - most recent fiscal year | 2.50 |
| Price to Tangible Book - most fiscal year | 2.67 |
| Price to Free Cash Flow per Share - most recent fiscal year | 8.59 |
| Price to Cash Flow per share - trailing 12 month | 6.08 |
| Price to Book - most recent fiscal year | 2.67 |
| P/E excluding extraordinary items high, trailing 12 months | 51.90 |
| P/E excluding extraordinary items low, trailing 12 months | 11.60 |
| Net Debt, LFI | 863.70 |
| Net Debt, LFY | 2,007.54 |
| Dividend Yield - 5 Year Average | 2.36% |
| Dividend Yield - indicated annual dividend divided by closing price | 4.02% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 4.11% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 437.69 |
| LT debt/equity - most recent fiscal year | 53.01% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 58.71% |
| LT debt/equity - most recent quarter | 55.22% |
| Total debt/total equity - most recent quarter | 60.12% |
| Free Cash Flow - trailing 12 month | 1,956.98 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 4,576.22 |
| Revenue - trailing 12 month | 6,725.42 |
| EBITD - most recent fiscal year | 1,477.11 |
| EBITD - trailing 12 month | 2,556.45 |
| Earnings before taxes - most recent fiscal year | 960.73 |
| Earnings before taxes - trailing 12 month | 2,462.45 |
| Net Income available to common - most recent fiscal year | 588.14 |
| Net Income available to common - trailing 12 months | 1,386.89 |
| Earnings before taxes Normalized - most recent fiscal year | 981.62 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 4.90 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 14.00% |
| Net Profit Margin % - trailing 12 month | 22.82% |
| Operating margin - 1st historical fiscal year | 23.37% |
| Operating margin - trailing 12 month | 38.54% |
| Pretax margin - trailing 12 month | 36.61% |
| Pretax margin - 1st historical fiscal year | 20.99% |
| Operating Margin - 5 year average | 33.91% |
| Pretax Margin - 5 year average | 32.14% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 9.30% |
| Free Operating Cash Flow/Revenue, TTM | 29.10% |
| Net Profit Margin - 5 year average | 19.79% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 5.27% |
| Return on average assets - trailing 12 month | 10.94% |
| Return on average equity - most recent fiscal year | 11.89% |
| Return on average equity - trailing 12 month | 26.74% |
| Return on average assets - 5 year average | 14.79% |
| Return on average equity - 5 year average | 33.71% |
| Net Income/employee - most recent fiscal year | 82,781.11 |
| Revenue/employee - most recent fiscal year | 591,319.81 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 20.29% |
| EPS growth rate, 5 year | 26.92% |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | 18.33% |
| Growth rate% - Revenue, 3 year | -24.68% |
| Growth rate% - EPS, 3 year | -46.80% |
| Book value per share growth rate, 5 year | 19.99% |
| Capital Spending growth rate, 5 year | 22.12% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 23.54% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
